Over the coming months we will be conducting a series of educational webcasts – please keep checking this page for regular updates.
cGMP Considerations in the Manufacture of Biologics
View this latest webcast by Linda Randall PhD, Operations Manager, to benefit from Eden's knowledge and insights into process development, facility design and quality management to overcome process challenges, cut costs and optimize your own process performance during the manufacture and regulatory approval of biopharmaceuticals.
Approaches to Bioprocess Characterisation
Philip Mellors, USP Development & Transfer Team Leader, outlines the core principles of bioprocess characterisation and the unique approach used by Eden Biodesign to optimize process performance and enhance product quality.
Biopharmaceutical Development: Creating and Maintaining Commercial Value during Outsourcing and Technology Transfer from Research to the Market
Eden Biodesign’s Chief Executive Officer, Dr. Crawford Brown, discusses the unique challenges of global biopharmaceutical development today and shares Eden Biodesign’s insights, processes and technology which can lower costs, speed time to market and optimize process performance. WATCH THE WEBCAST NOW.
Microscale to Manufacture for Emerging Vaccine Technologies
Senior Purification Development Scientist, Dr. Jonathan Souquet discusses the growing demand for adenoviral vectors and how Eden Biodesign’s robust and scalable platform purification strategy overcomes the challenges of traditional approaches to adenoviral downstream processing, while increasing development and production rates, and significantly lowering manufacturing costs.
Viral Vectors: Overcoming Process Challenges to Meet the Clinical Demands
Dr David Simpson, Process Development Manager, discusses the recent resurgence of live viral products, how traditional research-based processes are having a difficult time keeping pace and ways Eden Biodesign developed a scalable suspension-based process in response to these increasing demands.
Monoclonal Antibody Production: Building the Platform
Andrew Clutterbuck, Purification Development Team Leader, discusses the challenges facing antibody manufacturers and ways Eden Biodesign can help overcome these obstacles.
Novel HPLC Method to Accelerate The Development of Adenoviral Vaccines
Dr. Phil Ball, Technical Director, discusses a novel approach to accelerate the development of adenoviral vaccines.
Accelerating Novel Vaccine Development from Bench to Clinic
Dr Roger Lias, President, Eden Biodesign, Inc. explores the challenges facing entrepreneurial organizations in identifying and managing appropriate development partners that understand the technical and regulatory issues that need to be addressed in order to accelerate products into and through clinical development.